EFFECTIVENESS OF PLATELET TRANSFUSION IN DENGUE PATIENTS IN A TERTIARY CARE HOSPITAL

Objective: Dengue has been emerging as rapidly spreading and dreaded mosquito-borne disease caused by the bite of Aedes Aegypti Mosquito. Clinical features are variable presents with fever or Hemorrhagic more severe shock syndrome. Thrombocytopenia is presenting feature in all cases some often bleeding. Platelet transfusions given patients haemorrhagic symptoms. While medical fraternity globally recognizes role platelet transfusion management hospitalized dengue exact indications situations which these to be transfused may vary. Since there inherent risk associated blood/blood-component, it imperative for each institution (or country) lay their own criteria blood components. The present study was conducted precise trigger our setup.
 Methods: on 225 serologically confirmed admitted at sawaimansign Hospitals between 1" August 30th November 2022. data, reports hematological investigation, platelets requirements data obtained from SHealth services.
 Results: In cases, prevalence thrombocytopenia (count less than 100,000/cumm) 84.88% admission bleeding recorded 22 (9.7%) patients. About 96 (42.6%) received transfusion. Among them 47 (20.88%) had a count<20,000/cumm, 43 (19.11%) count range 21-40.000/cumm, while 6 (2.66%) 41 50.000/cumm. Out 49 count>20,000/cumm, 18 hemorrhagic manifestations such petechiae, gum-bleeding, epistaxis, etc., necessitates use However, 31 inappropriate transfusion.
 Conclusion: This suggests that occurs thrombocytopenia. High-risk having count<20,000/cumm require urgent Patients 21-40,000/cumm moderate only if they have any other superadded conditions.